Total Payments
$1,484
2024 Payments
$84.46
Companies
19
Transactions
41
Medicare Patients
1,459
Medicare Billing
$176,770
Payment Breakdown by Category
Food & Beverage$1,156 (77.9%)
Education$328.17 (22.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,156 | 20 | 77.9% |
| Education | $328.17 | 21 | 22.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Cardinal Health 108, LLC | $328.23 | 5 | $0 (2019) |
| PFIZER INC. | $223.43 | 15 | $0 (2021) |
| Heron Therapeutics, Inc. | $125.00 | 1 | $0 (2018) |
| TESARO, Inc. | $124.61 | 1 | $0 (2018) |
| Janssen Biotech, Inc. | $124.16 | 1 | $0 (2019) |
| Puma Biotechnology, Inc. | $118.60 | 1 | $0 (2019) |
| Kite Pharma, Inc. | $110.40 | 1 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $45.41 | 1 | $0 (2022) |
| Dendreon Pharmaceuticals LLC | $42.00 | 2 | $0 (2024) |
| Acrotech Biopharma LLC | $39.83 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $84.46 | 4 | Dendreon Pharmaceuticals LLC ($42.00) |
| 2023 | $52.49 | 2 | Pharmacyclics LLC, An AbbVie Company ($28.69) |
| 2022 | $67.04 | 2 | Alexion Pharmaceuticals, Inc. ($45.41) |
| 2021 | $120.18 | 8 | Acrotech Biopharma LLC ($39.83) |
| 2020 | $51.33 | 4 | PFIZER INC. ($51.33) |
| 2019 | $478.06 | 8 | Janssen Biotech, Inc. ($124.16) |
| 2018 | $471.20 | 10 | Cardinal Health 108, LLC ($130.40) |
| 2017 | $159.40 | 3 | Cardinal Health 108, LLC ($125.00) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/11/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: ONCOLOGY | ||||||
| 03/06/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 03/05/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 02/20/2024 | GENZYME CORPORATION | ALPROLIX (Biological), ALTUVIIIO | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Hematology | ||||||
| 03/06/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $28.69 | General |
| Category: ONCOLOGY | ||||||
| 02/08/2023 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Education | In-kind items and services | $23.80 | General |
| Category: Oncology | ||||||
| 10/25/2022 | Alexion Pharmaceuticals, Inc. | — | Education | In-kind items and services | $45.41 | General |
| 07/17/2022 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Oncology | ||||||
| 12/20/2021 | PFIZER INC. | LORBRENA (Drug) | Education | In-kind items and services | $15.50 | General |
| Category: ONCOLOGY | ||||||
| 08/17/2021 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: ONCOLOGY | ||||||
| 08/10/2021 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: ONCOLOGY | ||||||
| 07/21/2021 | Acrotech Biopharma LLC | BELEODAQ (Drug) | Education | In-kind items and services | $13.93 | General |
| Category: ONCOLOGY | ||||||
| 07/21/2021 | Acrotech Biopharma LLC | BELEODAQ (Drug) | Education | In-kind items and services | $11.97 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 03/24/2021 | Acrotech Biopharma LLC | BELEODAQ (Drug) | Education | In-kind items and services | $13.93 | General |
| Category: ONCOLOGY | ||||||
| 03/24/2021 | PFIZER INC. | INLYTA (Drug) | Education | In-kind items and services | $13.34 | General |
| Category: ONCOLOGY | ||||||
| 08/19/2020 | PFIZER INC. | INLYTA (Drug) | Education | In-kind items and services | $13.34 | General |
| Category: ONCOLOGY | ||||||
| 01/30/2020 | PFIZER INC. | XALKORI (Drug) | Education | In-kind items and services | $13.90 | General |
| Category: ONCOLOGY | ||||||
| 01/30/2020 | PFIZER INC. | BRAFTOVI (Drug), MEKTOVI | Education | In-kind items and services | $13.04 | General |
| Category: ONCOLOGY | ||||||
| 01/30/2020 | PFIZER INC. | LORBRENA (Drug) | Education | In-kind items and services | $11.05 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2019 | PFIZER INC. | LORBRENA (Drug) | Education | In-kind items and services | $11.05 | General |
| Category: ONCOLOGY | ||||||
| 10/07/2019 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $118.60 | General |
| Category: Oncology | ||||||
| 08/06/2019 | PFIZER INC. | VIZIMPRO (Drug) | Education | In-kind items and services | $15.32 | General |
| Category: ONCOLOGY | ||||||
| 08/06/2019 | PFIZER INC. | BAVENCIO (Drug) | Education | In-kind items and services | $14.65 | General |
| Category: ONCOLOGY | ||||||
| 08/06/2019 | PFIZER INC. | LORBRENA (Drug) | Education | In-kind items and services | $11.05 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 206 | 422 | $96,641 | $26,809 |
| 2022 | 7 | 309 | 621 | $134,723 | $37,797 |
| 2021 | 6 | 380 | 1,014 | $154,077 | $61,110 |
| 2020 | 9 | 564 | 1,481 | $128,354 | $51,054 |
Total Patients
1,459
Total Services
3,538
Medicare Billing
$176,770
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 171 | $50,484 | $14,317 | 28.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 126 | 232 | $45,872 | $12,352 | 26.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 14 | 19 | $285.00 | $139.61 | 49.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 73 | 235 | $67,865 | $19,909 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 150 | 270 | $53,382 | $13,748 | 25.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 14 | 21 | $5,397 | $1,704 | 31.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $4,706 | $1,294 | 27.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 17 | 21 | $2,388 | $633.96 | 26.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 30 | 47 | $705.00 | $361.67 | 51.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 12 | 14 | $280.00 | $146.99 | 52.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 113 | 411 | $92,640 | $37,374 | 40.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 156 | 342 | $52,506 | $19,275 | 36.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 12 | 34 | $5,134 | $1,877 | 36.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 55 | 144 | $1,152 | $1,105 | 95.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 15 | 20 | $1,952 | $815.16 | 41.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 29 | 63 | $693.00 | $665.28 | 96.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 82 | 318 | $61,620 | $25,015 | 40.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 178 | 431 | $56,252 | $21,329 | 37.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 109 | 275 | $4,369 | $2,056 | 47.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2020 | 57 | 116 | $2,532 | $1,191 | 47.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 93 | 177 | $814.71 | $508.62 | 62.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 11 | 19 | $1,415 | $504.79 | 35.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 12 | 32 | $1,000 | $293.44 | 29.3% |
| 80076 | Liver function blood test panel | Office | 2020 | 11 | 15 | $249.84 | $107.69 | 43.1% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2020 | 11 | 98 | $100.50 | $46.72 | 46.5% |
About Dr. Gordon Nakano, M.D
Dr. Gordon Nakano, M.D is a Hematology & Oncology healthcare provider based in Honolulu, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356318208.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gordon Nakano, M.D has received a total of $1,484 in payments from pharmaceutical and medical device companies, with $84.46 received in 2024. These payments were reported across 41 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,156).
As a Medicare-enrolled provider, Nakano has provided services to 1,459 Medicare beneficiaries, totaling 3,538 services with total Medicare billing of $176,770. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Honolulu, HI
- Active Since 02/28/2006
- Last Updated 01/12/2023
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1356318208
Products in Payments
- IMBRUVICA (Drug) $152.85
- SUSTOL (Drug) $125.00
- VARUBI (Drug) $124.61
- Nerlynx (Drug) $118.60
- Yescarta (Drug) $110.40
- LORBRENA (Drug) $48.65
- PROVENGE (Drug) $42.00
- MYLOTARG (Biological) $40.10
- BELEODAQ (Drug) $39.83
- PREVNAR - 13 (Biological) $29.29
- INLYTA (Drug) $26.68
- VENCLEXTA (Drug) $25.96
- XPOVIO (Drug) $23.80
- PROMACTA (Drug) $22.12
- BESPONSA (Biological) $21.80
- BRUKINSA (Drug) $21.63
- Perjeta (Biological) $21.33
- LUTATHERA (Drug) $17.47
- ALPROLIX (Biological) $16.50
- VIZIMPRO (Drug) $15.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Honolulu
Dr. Tamie Kerns, D.o, D.O
Hematology & Oncology — Payments: $74,809
Hematology & Oncology $74,809
Dr. Ryon Nakasone, Md, MD
Hematology & Oncology — Payments: $25,691
Hematology & Oncology $25,691
Dr. Melvin Palalay, M.d, M.D
Hematology & Oncology — Payments: $21,120
Hematology & Oncology $21,120
Dr. Arnold Yee, M.d, M.D
Hematology & Oncology — Payments: $17,453
Hematology & Oncology $17,453
Dr. Kenneth Sumida, M.d, M.D
Hematology & Oncology — Payments: $17,239
Hematology & Oncology $17,239
Dr. Jared Acoba, M.d, M.D
Hematology & Oncology — Payments: $14,082
Hematology & Oncology $14,082